IRIDEX (IRIX) EPS Estimated At $-0.33; BANKIA SA OTHER (BNKXF) Shorts Down By 14.12%

April 17, 2018 - By Steve Bissell

IRIDEX Corporation (NASDAQ:IRIX) Logo

BANKIA SA OTHER (OTCMKTS:BNKXF) had a decrease of 14.12% in short interest. BNKXF’s SI was 2.97 million shares in April as released by FINRA. Its down 14.12% from 3.46M shares previously. With 700 avg volume, 4245 days are for BANKIA SA OTHER (OTCMKTS:BNKXF)’s short sellers to cover BNKXF’s short positions. The SI to BANKIA SA OTHER’s float is 0.24%. It closed at $4.7 lastly. It is down 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Analysts expect IRIDEX Corporation (NASDAQ:IRIX) to report $-0.33 EPS on May, 2.They anticipate $0.17 EPS change or 106.25% from last quarter’s $-0.16 EPS. After having $-0.44 EPS previously, IRIDEX Corporation’s analysts see -25.00% EPS growth. The stock decreased 2.89% or $0.17 during the last trading session, reaching $5.71. About 2,405 shares traded. IRIDEX Corporation (NASDAQ:IRIX) has declined 53.54% since April 17, 2017 and is downtrending. It has underperformed by 65.09% the S&P500.

Among 3 analysts covering IRIDEX (NASDAQ:IRIX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. IRIDEX had 5 analyst reports since January 26, 2016 according to SRatingsIntel. The stock of IRIDEX Corporation (NASDAQ:IRIX) has “Buy” rating given on Wednesday, December 21 by TH Capital. On Tuesday, January 26 the stock rating was initiated by Singular Research with “Buy”. The firm earned “Buy” rating on Wednesday, December 21 by Roth Capital. Roth Capital maintained IRIDEX Corporation (NASDAQ:IRIX) on Sunday, February 25 with “Buy” rating.

Investors sentiment increased to 1.2 in Q4 2017. Its up 0.65, from 0.55 in 2017Q3. It improved, as 5 investors sold IRIDEX Corporation shares while 5 reduced holdings. 1 funds opened positions while 11 raised stakes. 5.52 million shares or 2.07% less from 5.63 million shares in 2017Q3 were reported. Finemark National Bank stated it has 37,581 shares or 0.02% of all its holdings. Paragon Associate Paragon Associate Ii Joint Venture stated it has 7.92% in IRIDEX Corporation (NASDAQ:IRIX). Wells Fargo Mn stated it has 9,360 shares or 0% of all its holdings. Thompson Davis And owns 500 shares for 0.01% of their portfolio. Tower Research Capital Ltd Limited Liability Company (Trc) holds 0.01% or 11,823 shares. National Bank & Trust Of New York Mellon owns 0% invested in IRIDEX Corporation (NASDAQ:IRIX) for 15,408 shares. 469 were reported by Jpmorgan Chase Com. California Pub Employees Retirement Systems accumulated 32,100 shares or 0% of the stock. Lyon Street Lc reported 1.23% stake. Blackrock Inc stated it has 28,161 shares. Northern Tru holds 58,299 shares. Millennium Ltd Liability reported 0% stake. Dimensional Fund Limited Partnership reported 201,395 shares. Deutsche Commercial Bank Ag reported 35,430 shares. Manufacturers Life Insur The reported 814 shares.

Since December 12, 2017, it had 1 buying transaction, and 1 insider sale for $22,756 activity. 2,806 shares were sold by Dizon Romeo R, worth $16,444 on Tuesday, March 13. Another trade for 5,000 shares valued at $39,200 was made by MOORE WILLIAM M on Tuesday, December 12.

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company has market cap of $66.39 million. The firm offers laser consoles, such as Cyclo G6 laser system used for the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It currently has negative earnings. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders.

Among 6 analysts covering Bankia (OTCMKTS:BNKXF), 1 have Buy rating, 4 Sell and 1 Hold. Therefore 17% are positive. Bankia had 6 analyst reports since September 3, 2015 according to SRatingsIntel. The rating was upgraded by Credit Suisse to “Neutral” on Thursday, September 3. The company was upgraded on Thursday, September 17 by Morgan Stanley. The stock of Bankia, S.A. (OTCMKTS:BNKXF) has “Sell” rating given on Wednesday, November 4 by Berenberg. The company was reinitiated on Wednesday, September 23 by Bank of America. The firm earned “Underperform” rating on Wednesday, February 8 by Keefe Bruyette & Woods. Jefferies downgraded the shares of BNKXF in report on Friday, January 20 to “Underperform” rating.

Bankia, S.A. provides banking and financial services and products primarily in Spain. The company has market cap of $13.81 billion. The firm operates in three divisions: Retail Banking, Business Banking, and Corporate Centre. It has a 22.49 P/E ratio. It provides retail banking products, such as salary direct deposits, mortgages, term deposits, credit cards, insurance, investment and pension funds, and other asset management services to high net-worth customers.

IRIDEX Corporation (NASDAQ:IRIX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Steve Bissell

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: